Rekovelle (F)

One pre-filled multidose pen delivers 12 micrograms follitropin delta* in 0.36 mL solution.

One mL of solution contains 33.3 micrograms of follitropin delta* Rekovelle 12mcg solution for injection in a pre-filled pen is indicated for controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.

There is no clinical trial experience with REKOVELLE in the long GnRH agonist protocol.

REKOVELLE is intended for subcutaneous use, preferably in the abdominal wall. The first injection should be performed under direct medical supervision. Patients must be educated on how to use the REKOVELLE injection pen and to perform injections. Self-administration should only be performed by patients who are well motivated, adequately trained and have access to expert advice.
user manual: https://rekovelle.ca/images/RekovellePrefilledPen-PatientTearSheetENG(DistributionCopy).pdf

Available on request.

Available on request.